期刊文献+

巨噬细胞炎症蛋白1α对多发性骨髓瘤细胞增殖与迁移能力的影响 被引量:3

原文传递
导出
出处 《中华血液学杂志》 CAS CSCD 北大核心 2005年第11期692-693,共2页 Chinese Journal of Hematology
基金 广东省科委攻关基金资助项目(C300303)
  • 相关文献

参考文献3

  • 1Michael G, Alexandrakis A, Freda H, et al. Evaluation of bone disease in multiple myeloma: a correlation between biochemical markers of bone metabolism and other linical parameters in untreated multiple myeloma patients. Clinic Chim Acta, 2002,325: 51-57.
  • 2Lentzsch S, Gries M, Janz M, et al. macrophage inflammatory protein-1 α (MIP-1 alpha) triggers migration and signaling cascades mediating survival and proliferation in multiple myeloma cells. Blood, 2003,101:3568-3573.
  • 3Uneda S, Hata H, Matsuno F, et al. Macrophage inflammatory protein-1 alpha is produced by human multiple myeloma (MM) cells and its expression correlates with bone lesions in patients with MM. Br J Haemato1,2003,120:53-55.

同被引文献38

  • 1王晓桃,罗绍凯,莫汉有,李娟,莫东华,周润华.巨噬细胞炎症蛋白-1α在多发性骨髓瘤中的表达[J].中山大学学报(医学科学版),2007,28(2):152-154. 被引量:6
  • 2Terpos E, Politou M, Viniou N, et al. Significance of macrophage inflammatory protein-I alpha( MIP-1alpha) in muhiple myeloma [ J]. Leuk Lymphoma, 2005,46 ( 12 ) : 1699 - 1707.
  • 3Hashimoto T,Abe M, Oshima T,et al Ability of myeloma cells to secrete macrophage inflammatory protein (MIP)-1 alpha and MIP- 1beta correlates with lytic bone lesions in patients with multiple myeloma[ J]. Br J Haematol, 2004,125 ( 1 ) :38 - 41.
  • 4Michael G,Alexandrakis A, Freda H, et al. Evaluation of bone disease in multiple myeloma: a correlation between biochemical markers of bone metabolism and other linical parameters in untreated multiple myeloma patients [ J ]. Clinic Chim Acta, 2002, 325(1-2) : 51 -57.
  • 5Moller C, Stromberg T, Juremalm M, et al. Expression and function of chemokine receptors in human multiple myeloma[ J]. Leukemia, 2003,17:203 - 210.
  • 6Giuliani N, Lisignoli G, Colla S, et al. CC-Chemokine ligand 20/macrophage inflammatory protein-3alpha and CC-ehemokine receptor 6 are overexpressed in myeloma mieroenvironment related to osteolytic bone lesions[ J]. Cancer Res, 2008,68 (16) :6840 - 6850.
  • 7Abe M, Hiura K, Wilde J, et al. Role for macrophage inflammatory protein(MIP)-1α and MIP-1β in the development of osteolytic lesions in muhiple myeloma [ J ]. Blood, 2002,100 ( 6 ) : 2195 - 2202.
  • 8Oba Y, Lee JW, Ehrlich LA, et al. MIP-lalpha utilizes both CCR1 and CCR5 to induce osteoclast formation and increase adhesion of myeloma cells to marrow stromal cells [ J ]. Exp Hematol, 2005,33 (3) :272 - 278.
  • 9Menu E, De Leenheer E, De Raeve H,et al. Role of CCR1 and CCR5 in homing and growth of multiple myeloma and in the development of osteolytic lesions: a study in the 5TMM model[ J]. Clin Exp Metastasis,2006,23 ( 545 ) : 291 - 300.
  • 10Vande BI, Leleu X, Schots R, et al. Clinical significance of chemokine receptor( CCR1, CCR2 and CXCR4) expression in human myeloma cells: the association with disease activity and survival[ J]. Haematologica,2007,92( 11 ) : 1584 - 1590.

引证文献3

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部